U.S. market Open. Closes in 5 hours 40 minutes

ILMN | Illumina, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 77.57 - 79.95
52 Week Range 77.55 - 156.66
Beta 1.43
Implied Volatility 54.42%
IV Rank 55.22%
Day's Volume 1,743,484
Average Volume 2,538,501
Shares Outstanding 158,400,000
Market Cap 12,567,456,000
Sector Healthcare
Industry Medical - Diagnostics & Research
IPO Date 2000-07-28
Valuation
Profitability
Growth
Health
P/E Ratio -10.32
Forward P/E Ratio N/A
EPS -7.69
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 10,590
Country USA
Website ILMN
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
ILMN's peers: A, CDNA, CRL, DHR, EXAS, FLGT, GH, IDXX, TMO, WAT, NTRA, TWST, ME, MYGN, OPK, PSNL
*Chart delayed
Analyzing fundamentals for ILMN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong. For more detailed analysis please see ILMN Fundamentals page.

Watching at ILMN technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ILMN Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙